$ 2.50
Today's Range
$2.47 - $2.55
52-Week Range
$2.08 - $4.14
Market Cap

About Volitionrx (NYSEAMERICAN:VNRX)

(NYSEAMERICAN:VNRX) VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. The company develops blood-based Nu.Q immunoassays to detect specific biomarkers. VolitionRx Limited is headquartered in Austin, Texas.
Show more

VNRX Stock Price

Statistics Highlights (NYSEAMERICAN:VNRX)

Shares Outstanding 63.56M Beta 1.65
Public Float 35.73M P/E Ratio -
% Short of Float - Dividend (Yield) -
Held by Insiders 35.25% Ex-Dividend Date
Held by Institutions 11.40% IPO Date Apr 25, 2007

VNRX Financial Summary

Dec 21 Dec 20 Dec 19
Revenue $90.03K $13.43K $17.10K
EBITDA $-25.69M $-19.23M $-15.07M
Net Income $32.00K $-20.35M $-16.10M
Total Assets $27.49M $26.15M $21.29M
Total Cash $20.58M $19.44M $16.97M
Total Debt $3.07B $4.53M $4.10M
Mar 22 Dec 21 Sep 21
Revenue $114.21K $14.24K $25.48K
EBITDA $-7.39M $-7.78M $-6.81M
Net Income $-7.72M $18.81M $-7.14M
Total Assets $31.68M $27.49M $30.00M
Total Cash $23.73M $20.58M $22.90M
Total Debt $ $3.07B $3.64M

VNRX Stock Price History

Volitionrx Annual Stock Price History

Year Open Close Change
2021 $3.11 $2.50 -19.61%
2021 $3.98 $3.11 -21.86%
2020 $4.61 $3.98 -13.67%

Volitionrx Daily Stock Price History

Date Open High Low Close Change Volume
Jun 9, 2022 $2.39 $2.49 $2.39 $2.44 17.31% 26.90K
Jun 22, 2022 $2.03 $2.10 $2.03 $2.08 -1.89% 23.13K
Jun 13, 2022 $2.31 $2.35 $2.10 $2.12 -14.86% 120.13K


What is today's stock price of Volitionrx (NYSEAMERICAN:VNRX)?

  • The current stock price of Volitionrx (NYSEAMERICAN:VNRX) is $2.50.
  • Today VNRX stock price opened at $2.50 after previous close of $2.56.
  • During the day, Volitionrx stock quote has varied from a low of $2.47 to a high of $2.55.

What is Volitionrx's 52-week change?

  • VNRX 52-week high stock quote is $4.14, which is 65.60% above the current share price.
  • The Volitionrx (NYSEAMERICAN:VNRX) 52-week low stock price is $2.08, which is 16.80% below the current share price.
  • Volitionrx share price volatility (52-week beta) is 1.65.

Is Volitionrx a buy?

  • According to 4 analysts, the current consensus recommendation for Volitionrx stock is "Strong Buy" at an average rating score of 4.75 (out of 5).
  • There are currently 3 "Strong Buy", 1 "Buy", 0 "Hold", 0 "Sell", and 0 "Strong Sell" analysts recommendations for the VNRX stock.
  • The 12 month average price target forecast for VNRX stock is $8.00, representing a 220.00% increase from the current VNRX stock price of $2.50.


How Much is Volitionrx Worth?

Volitionrx's worth today based on market capitalisation is $162.70M

How much dividend does Volitionrx Pay?

The current annualized dividend payout for VNRX stock is $0.00, the dividend yield is 0.00% and the payout ratio is 0.00%.
View More Details on Volitionrx's "Dividend" Section

When is the next earnings date for Volitionrx (NYSEAMERICAN:VNRX)?

Volitionrx is expected to report earnings on November 08 ,2022.
View More Details on Volitionrx's 'Earnings' Section

What is Volitionrx’s Price to Earning (PE) ratio?

VNRX stock also has a Price to Sales (P/S) ratio of 910.40, a Price to Book of 12.40 and Price/Earnings to Growth (PEG) of 0.00.

What is the Volitionrx's ticker?

Volitionrx trades on the NYSE American stock market in USA under the ticker symbol "VNRX". Volitionrx’s stock symbol can also be displayed as "NYSEAMERICAN:VNRX".

When did VNRX go public?

Volitionrx completed its initial public offering (IPO) on April 25 ,2007.

Who are the owners of Volitionrx?

Volitionrx (NYSEAMERICAN:VNRX) is owned by 11.39% institutional shareholders and by 35.25% insiders. The rest is owned by the public.
Explore More Details on Volitionrx's “Ownership” Section

Who are the key executives of Volitionrx (VNRX)?

Volitionrx's key executive team includes the following managers:

  • Dr. Martin Charles Faulkes Ph.D., Exec. Chairman (1944)
  • Mr. Cameron Reynolds MBA, Founder, Group CEO, Pres & Director (1971)
  • Mr. Terig Hughes, Group CFO & Treasurer (1971)
  • Dr. Jacob Vincent Micallef, Chief Scientific Officer (1956)
  • Dr. Salvatore Thomas Butera, Chief Exec. Officer of Volition Veterinary Diagnostics Devel. LLC (1951)
  • Dr. Gaetan Michel Ph.D., Chief Operating Officer (1973)
  • Dr. Mark Eccleston M.B.A., Ph.D., Chief Technology Officer (1971)
  • Mr. Scott Powell Ph.D., Exec. VP of Investor Relations & CFO of Volition America Inc (1974)
  • Mr. Nicholas Plummer, Group Gen. Counsel (1971)
  • Ms. Louise Batchelor Day, Chief Marketing & Communications Officer (NA)

What is Volitionrx’s Sector & Industry Classification?

Volitionrx (NYSEAMERICAN:VNRX) is classified under the "Healthcare" sector and under the "Diagnostics & Research" industry.

How many employees work for Volitionrx?

Currently the number of employees working for Volitionrx is 83.

Where are Volitionrx's Headquarters?

Volitionrx (NYSEAMERICAN:VNRX) is headquartered in TX, United States.

What are Volitionrx's Address and Phone Number?

Volitionrx’s mailing address is 13215 Bee Cave Parkway, Austin, TX, United States, 78738.
The company’s phone number is 646 650 1351.

What is the official website for Volitionrx?

Volitionrx’s official website is http://www.volition.com